Hexaware Positioned as a Leader in ISG’s Global 2024 Life Sciences Digital Services Report
June 28, 2024
Hexaware has been positioned as a Leader in two quadrants of the ISG Provider Lens™ Life Sciences Digital Services – Global 2024 report: Clinical Development and Patient Engagement. The report, published by global technology research and advisory firm ISG, assesses service providers based on their capabilities to support digital transformation across the life sciences value chain.
Hexaware was also identified as a Rising Star in the Commercial Operations – Digital Evolution quadrant, reflecting its momentum and future potential in that domain.
Clinical Development: Modular, AI-Enabled Trial Support
In the Clinical Development quadrant, ISG noted Hexaware’s suite of solutions that includes a modular Decentralized Clinical Trials (DCT) Platform, Clinical Process Automation as a Service, and Clinical Data as a Service. These offerings incorporate AI and GenAI to automate trial workflows and improve operational efficiency.
Key features highlighted include:
- DCT Platform modules for precision medicine, vaccine, and CGT studies
- Support for eConsent, ePRO, eCOA, and contact centers
- AI-based automation for tasks like file standardization and trial data processing
- Cognitive Contact Center and integrated AI for accelerated insights
Patient Engagement: Integrated Digital Solutions with IoT Support
In the Patient Engagement quadrant, ISG referenced Hexaware’s use of Salesforce Cloud-integrated accelerators and pre-integrated IoT devices (e.g., Apple Watch, Fitbit, BP monitors) to support real-time health tracking and patient interaction.
Noted capabilities include:
- Prebuilt hubs for eConsent, outreach, and engagement
- Integration with devices to streamline health data collection and response
- Secure data exchange supported by partnerships with MuleSoft, Apigee, Boomi, and Microsoft FHIR APIs
- Customization support for EDC and CRM integration using SnapLogic
Commercial Operations: Recognized as a Rising Star
Hexaware was recognized as a Rising Star in the Commercial Operations quadrant. ISG cited Hexaware’s:
- Exclusive systems integrator partnership with IQVIA’s Human Data Science Cloud (HDSC)
- Validated Salesforce-based cell and gene platform for manufacturing support
- Field force solutions and omnichannel engagement platforms including PSP Blue and other accelerators for patient and HCP engagement
A Global Partner for Digital Transformation in Life Sciences
Hexaware’s inclusion in multiple quadrants reflects its end-to-end capabilities in transforming the life sciences industry with automation, analytics, cloud-native platforms, and integrated patient and HCP engagement solutions.
Hexaware Named a Leader in Clinical Development in the ISG Provider Lens™ Life Sciences Digital Services 2024 Global Quadrant Study
“Hexaware transforms clinical operations with advanced solutions, driving efficiency and improving patient care.”
— Rohan Sinha, Lead Author, Life Sciences Digital Services Study
Hexaware Named a Leader in Patient Engagement in the ISG Provider Lens™ Life Sciences Digital Services 2024 Global Quadrant Study
“Hexaware redefines patient engagement by seamlessly integrating tailored accelerators and advanced data solutions.”
— Rohan Sinha, Lead Author, Life Sciences Digital Services Study
Hexaware Named a Rising Star in Commercial Operations – Digital Evolution in the ISG Provider Lens™ Life Sciences Digital Services 2024 Global Quadrant Study
“In the dynamic landscape of pharma commercial operations, Hexaware is a beacon of innovation, driving transformative solutions with precision and expertise”
— Sneha Jayanth, Co-Author and Research Analyst, Life Sciences Digital Services Study
To learn more, visit our Life Sciences and Healthcare Services page.